SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Solara Active Pharma Sciences informs about analyst meet

11 May 2026 Evaluate

Solara Active Pharma Sciences has informed that the Company has scheduled a conference call with analysts/ investors to discuss Company’s audited financial results for the quarter and financial year ended March 31, 2026 on Friday, May 15, 2026 at 03:00 pm (IST). Analysts / Investors Conference Call details are enclosed. Further, the above information will also be available on the website of the Company: https://solara.co.in/investor-relations/schedule-of-investors-meet-and-investors-presentations.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

572.55 0.00 (0.00%)
10-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1787.10
Dr. Reddys Lab 1271.75
Cipla 1376.25
Zydus Lifesciences 1097.90
Lupin 2248.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×